Latest filing published 03 Nov 2020 for RAPT Therapeutics, Inc., €49k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Karen C. Lam: trading record in brief
Karen C. Lam appears in our data through filings on RAPT Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 7 May 2020 and the latest from 2 November 2020.
On the market, this insider has only sold: 2 sales, €75k in total. Besides market trades, the filings include 1 option exercise.
The latest filing, published on 3 November 2020, reports an open-market sale of €49k in RAPT Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karen C. Lam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,022 shares@ US$28.14Common StockSEC:0001593968-20-002125:0
- 2,777 shares@ US$1.86Common StockSEC:0001209191-20-028890:0
- 1,831 shares@ US$15.40Common StockSEC:0001209191-20-028012:0
3 of 3 declarations